Samuel Z. Goldhaber and Alexander G.G. Turpie Prevention of Venous Thromboembolism Among Hospitalized Medical Patients
نویسنده
چکیده
Prevention of Venous Thromboembolism Among Hospitalized Medical Patients Print ISSN: 0009-7322. Online ISSN: 1524-4539 Copyright © 2005 American Heart Association, Inc. All rights reserved. is published by the American Heart Association, 7272 Greenville Avenue, Dallas, TX 75231 Circulation doi: 10.1161/01.CIR.0000150393.51958.54 2005;111:e1-e3 Circulation. http://circ.ahajournals.org/content/111/1/e1 World Wide Web at: The online version of this article, along with updated information and services, is located on the
منابع مشابه
Prevention of venous thromboembolism among hospitalized medical patients.
Case presentation: A 79-yearold woman was noted by staff at her skilled nursing facility to have increasing shortness of breath during the previous 24 to 48 hours. She had been receiving daily physical therapy, occupational therapy, and 6 prescription medications to manage underlying congestive heart failure with preserved systolic function. The woman was hospitalized. After being transferred t...
متن کاملRandomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients.
BACKGROUND Considerable variability exists in the use of pharmacological thromboprophylaxis among acutely ill medical patients, partly because clinically relevant end points have not been fully assessed in this population. We undertook an international, multicenter, randomized, double-blind, placebo-controlled trial using clinically important outcomes to assess the efficacy and safety of daltep...
متن کاملPhysician alerts to prevent symptomatic venous thromboembolism in hospitalized patients.
BACKGROUND Venous thromboembolism (VTE) prophylaxis remains underused among hospitalized patients. We designed and carried out a large, multicenter, randomized controlled trial to test the hypothesis that an alert from a hospital staff member to the attending physician will reduce the rate of symptomatic VTE among high-risk patients not receiving prophylaxis. METHODS AND RESULTS We enrolled p...
متن کاملReal-world data confirm clinical trial outcomes for rivaroxaban in orthopaedic patients
Venous thromboembolism (VTE) is a potential cause of morbidity and mortality in patients after major orthopaedic surgery. Based on the results of the international phase III RECORD (Regulation of Coagulation in Orthopaedic Surgery to Prevent Deep Vein Thrombosis and Pulmonary Embolism) program, the oral, direct Factor Xa inhibitor rivaroxaban has been approved in many countries for the preventi...
متن کاملAdvances in oral anticoagulation treatment: the safety and efficacy of rivaroxaban in the prevention and treatment of thromboembolism
Arterial and venous thromboembolic diseases are a clinical and economic burden worldwide. In addition to traditional agents such as vitamin K antagonists and heparins, newer oral agents - such as the factor Xa inhibitors rivaroxaban, apixaban, and edoxaban, and the direct thrombin inhibitor dabigatran - have been shown to be effective across several indications. Rivaroxaban has been shown to ha...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2004